Aminopyrazole triazolothiadiazole inhibitors of c-met protein kinase
    6.
    发明授权
    Aminopyrazole triazolothiadiazole inhibitors of c-met protein kinase 有权
    c-met蛋白激酶的氨基吡唑三唑并噻二唑抑制剂

    公开(公告)号:US08269012B2

    公开(公告)日:2012-09-18

    申请号:US12788608

    申请日:2010-05-27

    IPC分类号: C07D215/12 A61K31/47

    CPC分类号: C07D513/04

    摘要: The present invention relates to compounds of formula I, which is useful in the inhibition of c-Met protein kinase. The invention also provides pharmaceutically acceptable compositions comprising compounds of formula I and methods of using the compositions in the treatment of proliferative disorders.

    摘要翻译: 本发明涉及式I化合物,其可用于抑制c-Met蛋白激酶。 本发明还提供包含式I化合物的药学上可接受的组合物和使用该组合物治疗增殖性疾病的方法。

    AMINOPYRAZOLE TRIAZOLOTHIADIAZOLE INHIBITORS OF C-MET PROTEIN KINASE
    9.
    发明申请
    AMINOPYRAZOLE TRIAZOLOTHIADIAZOLE INHIBITORS OF C-MET PROTEIN KINASE 审中-公开
    C-MET蛋白激酶的氨基吡唑三唑并噻唑类抑制剂

    公开(公告)号:US20130018072A1

    公开(公告)日:2013-01-17

    申请号:US13621396

    申请日:2012-09-17

    CPC分类号: C07D513/04

    摘要: The present invention relates to compounds of formula I, which is useful in the inhibition of c-Met protein kinase. The invention also provides pharmaceutically acceptable compositions comprising compounds of formula I and methods of using the compositions in the treatment of proliferative disorders.

    摘要翻译: 本发明涉及式I化合物,其可用于抑制c-Met蛋白激酶。 本发明还提供包含式I化合物的药学上可接受的组合物和使用该组合物治疗增殖性疾病的方法。